Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C7H5O3.Cu |
| Molecular Weight | 337.772 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cu++].OC1=C(C=CC=C1)C([O-])=O.OC2=C(C=CC=C2)C([O-])=O
InChI
InChIKey=CMRVDFLZXRTMTH-UHFFFAOYSA-L
InChI=1S/2C7H6O3.Cu/c2*8-6-4-2-1-3-5(6)7(9)10;/h2*1-4,8H,(H,9,10);/q;;+2/p-2
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/367963
Sources: https://www.ncbi.nlm.nih.gov/pubmed/367963
Cupric salicylate is an anti-inflammatory agent which was used as pain relief for patients with osteoarthritis, rheumatoid and other degenerative diseases (as a copper-salicylate complex). The preparation seem to be discontinued for now.
CNS Activity
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The effect of ionic strength on the complexation of copper (II) with salicylate ion. | 2002-07-20 |
|
| Copper-salicylate gel for pain relief in osteoarthritis: a randomised controlled trial. | 1997-08-04 |
|
| Copper salicylate as an anti-inflammatory and analgesic agent in arthritic rats. | 1983-02-28 |
|
| Treatment of rheumatoid and degenerative diseases with copper complexes: a review with emphasis on copper-salicylate. | 1977-09 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
I11SQ4NX1R
Created by
admin on Mon Mar 31 21:20:06 GMT 2025 , Edited by admin on Mon Mar 31 21:20:06 GMT 2025
|
PRIMARY | |||
|
SUB13459MIG
Created by
admin on Mon Mar 31 21:20:06 GMT 2025 , Edited by admin on Mon Mar 31 21:20:06 GMT 2025
|
PRIMARY | |||
|
16048-96-7
Created by
admin on Mon Mar 31 21:20:06 GMT 2025 , Edited by admin on Mon Mar 31 21:20:06 GMT 2025
|
PRIMARY | |||
|
240-194-6
Created by
admin on Mon Mar 31 21:20:06 GMT 2025 , Edited by admin on Mon Mar 31 21:20:06 GMT 2025
|
PRIMARY | |||
|
Cupric salicylate
Created by
admin on Mon Mar 31 21:20:06 GMT 2025 , Edited by admin on Mon Mar 31 21:20:06 GMT 2025
|
PRIMARY | |||
|
100000079805
Created by
admin on Mon Mar 31 21:20:06 GMT 2025 , Edited by admin on Mon Mar 31 21:20:06 GMT 2025
|
PRIMARY | |||
|
54683201
Created by
admin on Mon Mar 31 21:20:06 GMT 2025 , Edited by admin on Mon Mar 31 21:20:06 GMT 2025
|
PRIMARY | |||
|
m3909
Created by
admin on Mon Mar 31 21:20:06 GMT 2025 , Edited by admin on Mon Mar 31 21:20:06 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID80936318
Created by
admin on Mon Mar 31 21:20:06 GMT 2025 , Edited by admin on Mon Mar 31 21:20:06 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD